7-3-4-9　ⓔ文献

  1. Tanaka T, Takahashi H, et al: A nosocomial outbreak of febrile bloodstream infection caused by heparinized–saline contaminated with Serratia marcescens, Tokyo, 2002. Jpn J Infect Dis, 2004; 57: 189–192.

  2. Nakashima AK, McCarthy MA, et al: Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic. J Clin Microbol, 1987; 25: 1014–1018.

  3. Crémet L, Bourigault C, et al: Nosocomial outbreak of carbapenem–resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora. J Antimicrob Chemother, 2012; 67: 1041–1043.

  4. Gaibani P, Ambretti S, et al: Outbreak of Citrobacter freundii carrying VIM–1 in an Italian hospital, identified during the carbapenemases screening actions, June 2012. Int J Infect Dis, 2013; 17: e714–e717.

  5. Novak A, Goic-Barisic I, et al: Monoclonal outbreak of VIM–1–carbapenemase–producing Enterobacter cloacae in intensive care unit, university hospital centre split, Croatia. Microb Drug Resist, 2014; 20: 399–403.

  6. Tuon FF, Cordova K, et al: Klebsiella pneumoniae carbapenemase–producing Serratia marcescens outbreak in a university hospital. Am J Infect Control, 2017; 45: 700–702.

  7. Miltgen G, Bonnin RA, et al: Outbreak of IMI–1 carbapenemase-producing colistin–resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean). Int J Antimicrob Agents, 2018; 52: 416–420.

  8. Shin S, Jeong SH, et al: Emergence of multidrug–resistant Providencia rettgeri isolates co–producing NDM–1 carbapenemase and PER–1 extended–spectrum β–lactamase causing a first outbreak in Korea. Ann Clin Microbiol Antimicrob, 2018; 17: 20.